Cipla reported 38.39 in PE Price to Earnings for its fiscal quarter ending in September of 2026.





Pe Change Date
Brainstorm Cell Therapeutics 0.03 5.89 Sep/2025
Capricor Therapeutics 2.76K 2.76K Dec/2022
Cara Therapeutics 0.49 27.28 Mar/2026
Cipla 38.39 2.57 Sep/2026
Dr.Reddys Laboratories 35.92 2.77 Sep/2026
Sun Pharmaceuticals 37.28 1.1 Sep/2026
TherapeuticsMD 0.75 3.3 Mar/2023
UPL 22.66 1.39 Sep/2026